These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36820891)

  • 1. Validation of simplified uptake measures against dynamic Patlak K
    Wijngaarden JE; Huisman MC; Jauw YWS; van Dongen GAMS; Greuter HNJM; Schuit RC; Cleveland M; Gootjes EC; Vugts DJ; Menke-van der Houven van Oordt CW; Boellaard R
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1897-1905. PubMed ID: 36820891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal imaging time points considering accuracy and precision of Patlak linearization for
    Wijngaarden JE; Huisman MC; Pouw JEE; Menke-van der Houven van Oordt CW; Jauw YWS; Boellaard R
    EJNMMI Res; 2022 Sep; 12(1):54. PubMed ID: 36065038
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Miedema IHC; Wijngaarden JE; Pouw JEE; Zwezerijnen GJC; Sebus HJ; Smit E; de Langen AJ; Bahce I; Thiele A; Vugts DJ; Boellaard R; Huisman MC; Menke-van der Houven van Oordt CW
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067257
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jauw YWS; O'Donoghue JA; Zijlstra JM; Hoekstra OS; Menke-van der Houven van Oordt CW; Morschhauser F; Carrasquillo JA; Zweegman S; Pandit-Taskar N; Lammertsma AA; van Dongen GAMS; Boellaard R; Weber WA; Huisman MC
    J Nucl Med; 2019 Dec; 60(12):1825-1832. PubMed ID: 31147401
    [No Abstract]   [Full Text] [Related]  

  • 5. Immuno-PET Imaging to Assess Target Engagement: Experience from
    Menke-van der Houven van Oordt CW; McGeoch A; Bergstrom M; McSherry I; Smith DA; Cleveland M; Al-Azzam W; Chen L; Verheul H; Hoekstra OS; Vugts DJ; Freedman I; Huisman M; Matheny C; van Dongen G; Zhang S
    J Nucl Med; 2019 Jul; 60(7):902-909. PubMed ID: 30733323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-specific irreversible
    Wijngaarden JE; Jauw YWS; Zwezerijnen GJC; de Wit-van der Veen BJ; Vugts DJ; Zijlstra JM; van Dongen GAMS; Boellaard R; Menke-van der Houven van Oordt CW; Huisman MC
    EJNMMI Res; 2024 Feb; 14(1):18. PubMed ID: 38358425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
    Jauw YWS; Heijtel DF; Zijlstra JM; Hoekstra OS; de Vet HCW; Vugts DJ; Verheul HM; Boellaard R; Zweegman S; van Dongen GAMS; der Houven van Oordt CWM; Lammertsma AA; Huisman MC
    Mol Imaging Biol; 2018 Dec; 20(6):1025-1034. PubMed ID: 29713958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
    Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI.
    Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
    Mol Imaging Biol; 2019 Dec; 21(6):1147-1156. PubMed ID: 30838550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis and simplified uptake measures for tumour lesion [
    Wijngaarden JE; Slebe M; Pouw JEE; Oprea-Lager DE; Schuit RC; Dickhoff C; Levi J; Windhorst AD; Oordt CWMHV; Thiele A; Bahce I; Boellaard R; Yaqub M
    Eur J Nucl Med Mol Imaging; 2024 Oct; ():. PubMed ID: 39377810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing
    Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ
    Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver reproducibility of tumor uptake quantification with
    Jauw YWS; Bensch F; Brouwers AH; Hoekstra OS; Zijlstra JM; Pieplenbosch S; Schröder CP; Zweegman S; van Dongen GAMS; Menke-van der Houven van Oordt CW; de Vries EGE; de Vet HCW; Boellaard R; Huisman MC
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1840-1849. PubMed ID: 31209514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Analysis of Heterogeneous [
    Zhuang M; Karakatsanis NA; Dierckx RAJO; Zaidi H
    Mol Imaging Biol; 2019 Apr; 21(2):317-327. PubMed ID: 29956119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
    Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
    J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified Methods for Quantification of
    Jansen BHE; Yaqub M; Voortman J; Cysouw MCF; Windhorst AD; Schuit RC; Kramer GM; van den Eertwegh AJM; Schwarte LA; Hendrikse NH; Vis AN; van Moorselaar RJA; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2019 Dec; 60(12):1730-1735. PubMed ID: 31000583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.
    Karakatsanis NA; Zhou Y; Lodge MA; Casey ME; Wahl RL; Zaidi H; Rahmim A
    Phys Med Biol; 2015 Nov; 60(22):8643-73. PubMed ID: 26509251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach.
    Even AJ; Hamming-Vrieze O; van Elmpt W; Winnepenninckx VJ; Heukelom J; Tesselaar ME; Vogel WV; Hoeben A; Zegers CM; Vugts DJ; van Dongen GA; Bartelink H; Mottaghy FM; Hoebers F; Lambin P
    Oncotarget; 2017 Jan; 8(3):3870-3880. PubMed ID: 27965472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy.
    Magro N; Oteo M; Romero E; Ibáñez-Moragues M; Lujan VM; Martínez L; Vela O; López-Melero ME; Arroyo AG; Garaulet G; Martínez-Torrecuadrada JL; Mulero F; Morcillo MA
    Nucl Med Biol; 2024; 136-137():108930. PubMed ID: 38833768
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bensch F; Lamberts LE; Smeenk MM; Jorritsma-Smit A; Lub-de Hooge MN; Terwisscha van Scheltinga AGT; de Jong JR; Gietema JA; Schröder CP; Thomas M; Jacob W; Abiraj K; Adessi C; Meneses-Lorente G; James I; Weisser M; Brouwers AH; de Vries EGE
    Clin Cancer Res; 2017 Oct; 23(20):6128-6137. PubMed ID: 28733442
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks.
    Zaker N; Haddad K; Faghihi R; Arabi H; Zaidi H
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4048-4063. PubMed ID: 35716176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.